HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Stefano Colloca Selected Research

Stefano Colloca Research Topics

Disease

18Infections
06/2022 - 05/2005
16Malaria
01/2018 - 02/2006
10Vaccinia
01/2020 - 05/2014
9Neoplasms (Cancer)
01/2020 - 01/2008
4Falciparum Malaria (Plasmodium falciparum Malaria)
01/2013 - 12/2011
3COVID-19
01/2022 - 01/2021
3Viremia
04/2017 - 02/2006
3Persistent Infection
08/2016 - 05/2014
3Communicable Diseases (Infectious Diseases)
12/2015 - 03/2012
2Rabies (Hydrophobia)
04/2021 - 01/2020
2Chronic Hepatitis C
08/2016 - 05/2016
2Respiratory Tract Infections (Respiratory Tract Infection)
08/2015 - 01/2015
2Tuberculosis (Tuberculoses)
03/2015 - 03/2012
2Bites and Stings (Sting)
03/2015 - 12/2012
1Colorectal Neoplasms (Colorectal Cancer)
01/2020
1Microsatellite Instability
01/2020
1Junctional Epidermolysis Bullosa (Epidermolysis Bullosa Letalis)
11/2018
1Visceral Leishmaniasis (Kala Azar)
05/2017
1Leishmaniasis
05/2017
1Papillomavirus Infections
02/2017
1Ebola Hemorrhagic Fever
01/2017
1Reinfection
08/2016
1Virus Diseases (Viral Diseases)
05/2016
1Vesicular Stomatitis
04/2016
1Respiratory Tract Diseases (Respiratory Tract Disease)
08/2015
1Injection Site Reaction
08/2015
1Lung Diseases (Lung Disease)
08/2015
1Necrosis
01/2014
1Human Influenza (Influenza)
01/2013
1Acquired Immunodeficiency Syndrome (AIDS)
03/2012
1Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2012
1Hepatitis
02/2006

Drug/Important Bio-Agent (IBA)

37VaccinesIBA
01/2022 - 02/2006
21AntigensIBA
01/2020 - 02/2009
12Proteins (Proteins, Gene)FDA Link
06/2022 - 05/2005
5Neutralizing AntibodiesIBA
01/2020 - 05/2014
4AntibodiesIBA
01/2021 - 01/2008
4EpitopesIBA
01/2018 - 02/2006
3Adenovirus VaccinesIBA
01/2021 - 05/2014
3ThrombospondinsIBA
01/2018 - 01/2013
3Antiviral Agents (Antivirals)IBA
08/2016 - 05/2014
2Peptides (Polypeptides)IBA
01/2020 - 01/2012
2Glycoproteins (Glycoprotein)IBA
01/2020 - 04/2016
21- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA
04/2015 - 01/2013
2Malaria VaccinesIBA
01/2013 - 12/2012
2Merozoite Surface Protein 1 (MSA1)IBA
12/2012 - 12/2011
1Cancer VaccinesIBA
01/2020
1DNA (Deoxyribonucleic Acid)IBA
01/2020
1Messenger RNA (mRNA)IBA
01/2020
1Neoplasm Antigens (Tumor Antigens)IBA
01/2019
1KalininIBA
11/2018
1Papillomavirus Vaccines (HPV Vaccines)IBA
02/2017
1invariant chain (Ii-Key)IBA
01/2014
1Synthetic Vaccines (Recombinant Vaccines)IBA
03/2013
1NucleoproteinsIBA
01/2013
1Subunit VaccinesIBA
01/2013
1Recombinant ProteinsIBA
01/2012
1Biological ProductsIBA
01/2008

Therapy/Procedure

2Therapeutics
12/2015 - 03/2012
1Drug Therapy (Chemotherapy)
05/2017
1Immunotherapy
02/2006